CAAS Capital Management’s DexCom DXCM Stock Holding History

CAAS Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200	Closed	-$27.7K	–	307
2024 Q1	$27.7K	Sell	200 -12,700	-98%	-$1.6M	﹤0.01%	456
2023 Q4	$1.6M	Buy	+12,900	New	+$1.32M	0.17%	135
2023 Q2	–	Sell	-24,700	Closed	-$2.87M	–	723
2023 Q1	$2.87M	Sell	24,700 -107,300	-81%	-$12M	0.15%	146
2022 Q4	$14.9M	Hold	132,000	–	–	0.9%	10
2022 Q3	$10.6M	Hold	132,000	–	–	0.51%	29
2022 Q2	$9.84M	Hold	132,000	–	–	0.49%	44
2022 Q1	$16.9M	Sell	132,000 -119,200	-47%	-$13M	0.69%	37
2021 Q4	$33.7M	Hold	251,200	–	–	0.82%	22
2021 Q3	$34.3M	Hold	251,200	–	–	0.69%	29
2021 Q2	$26.8M	Buy	251,200 +175,200	+231%	+$16.8M	0.45%	47
2021 Q1	$6.83M	Sell	76,000 -164,000	-68%	-$15.4M	0.07%	287
2020 Q4	$22.2M	Buy	+240,000	New	+$21.4M	0.21%	100
2020 Q2	–	Sell	-18,000	Closed	-$1.21M	–	424
2020 Q1	$1.21M	Buy	+18,000	New	+$1.12M	0.13%	126

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CAAS Capital Management's DXCM Position: Q2 2023 in Review

CAAS Capital Management sold out of DexCom (DXCM) in Q2 2023, closing a stake of 1,600 shares — an estimated $186K sold.

CAAS Capital Management first reported a position in DXCM in Q4 2020 and held it in 6 quarters. The position peaked at $5.82M in Q1 2021. 954 funds tracked by Wall St. Rank hold DXCM as of Q2 2023.

CAAS Capital Management reported no remaining DexCom position as of Q2 2023 after selling out during the quarter.
CAAS Capital Management sold 1,600 DexCom shares in Q2 2023, an estimated $186K.
CAAS Capital Management first reported a position in DexCom in Q4 2020 and held it in 6 quarters.
CAAS Capital Management's DexCom position peaked at $5.82M in Q1 2021.
954 funds tracked by Wall St. Rank held DexCom as of Q2 2023.

Based on CAAS Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.